Sintilimab Combined With Bevacizumab for Brain Metastases From Non-small Cell Lung Cancer
Clinical trial NCT04213170 · UNKNOWN
Trial details
- NCT number
- NCT04213170
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-29
- Primary completion
- 2022-12-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.